In March 2025, the company announced new plans for your immediate-to-purchaser presenting of its Wegovy weight loss drug. The company established a new pharmacy, named NovoCare, which might demand customers $499 a month for access to the drug, fewer than half the cost of the drug by way of other pharmaceutical distribution networks.[53]The company